Oral Estradiol Cost in Wisconsin 2026: Cash Pay, Insurance, and Compounded Options

What Does Oral Estradiol Actually Cost in Wisconsin Right Now?

The average cash-pay price for oral estradiol tablets at Wisconsin retail pharmacies in 2026 is approximately $15 per month. That is considerably less than the manufacturer list price of around $40 per month for branded generic products. Prices vary by pharmacy, dose, and quantity, so checking multiple sources before filling saves real money.

Oral estradiol (17-beta-estradiol) is available as generic tablets in strengths of 0.5 mg, 1 mg, and 2 mg. Because the patent on estradiol expired decades ago, the market is crowded with generic manufacturers, which keeps retail prices low [1]. The FDA has approved oral estradiol for the treatment of moderate-to-severe vasomotor symptoms of menopause, vulvar and vaginal atrophy, and hypoestrogenism caused by hypogonadism, castration, or primary ovarian insufficiency [2].

Price variation across Wisconsin is real. A GoodRx query on a 30-tablet supply of estradiol 1 mg shows prices ranging from under $10 at discount club pharmacies (Costco, Sam's Club) to $25 at full-price retail chains without a coupon. Expressing your willingness to use a discount program at the pharmacy counter is one of the simplest steps a patient can take. The North American Menopause Society (NAMS) 2022 Position Statement notes that "cost and access remain barriers to guideline-concordant hormone therapy for many women," a point that applies directly to Wisconsin patients comparing pharmacy options [3].

GoodRx, RxSaver, and the NeedyMeds database all list Wisconsin-specific prices. Comparing three or four coupon codes before presenting to the pharmacy counter takes under five minutes online and can save $10 to $20 on a single fill.

How Wisconsin Medicaid Handles Oral Estradiol Coverage

Wisconsin Medicaid (ForwardHealth) covers oral estradiol but requires a prior authorization (PA) in most cases. PA is not automatic. The prescriber must document the clinical indication, typically moderate-to-severe vasomotor symptoms of menopause or another FDA-approved indication, before the plan will pay [4].

Submitting a PA is the prescriber's responsibility, not the patient's. The PA form for hormone therapy through ForwardHealth asks for diagnosis codes (ICD-10 N95.1 for menopausal and female climacteric states), symptom severity, and a statement that the drug is medically necessary. Approval timelines for non-urgent PA requests in Wisconsin average 3 to 5 business days [5].

Once approved, the copay tier for most Wisconsin Medicaid enrollees for a preferred generic is $1 to $3 per fill. That brings the monthly cost of oral estradiol well below the already-low cash-pay price. Patients on BadgerCare Plus, the Wisconsin Medicaid expansion program that covered approximately 1.2 million residents in 2024, follow the same PA pathway [6].

If a PA is denied, the prescriber can file an appeal. Common grounds for appeal include documentation that the patient has tried and failed non-hormonal options, or that clinical guidelines (specifically the NAMS 2022 Position Statement and the Endocrine Society's 2015 guideline on female hypogonadism) support hormone therapy for the stated indication [3, 7].

Is Compounded Oral Estradiol Legal in Wisconsin?

Yes. Compounded oral estradiol is legal in Wisconsin when prepared by a state-licensed 503A compounding pharmacy operating under a valid prescription for an individual patient [8]. Federal law under the Drug Quality and Security Act (DQSA) of 2013 governs 503A pharmacies and requires they compound only pursuant to a valid patient-specific prescription [9].

503A pharmacies in Wisconsin are regulated jointly by the Wisconsin Pharmacy Examining Board and the FDA. They may prepare custom-dose estradiol oral preparations, including doses not commercially available (for example, 0.25 mg tablets), when there is a documented clinical need. Wisconsin does not prohibit 503A compounding of estradiol specifically, and no state-level restriction singles out estradiol among compounded hormone products [10].

Cost is a major reason patients and prescribers consider compounded estradiol. For patients with specific insurance arrangements, prior authorization approval through certain specialty compounding benefit plans, or participation in specific patient-assistance programs, the out-of-pocket cost for compounded estradiol oral preparations can fall to $0 per month. That figure depends on the individual arrangement and is not universal.

The FDA has issued guidance cautioning that compounded hormone products are not FDA-approved and have not gone through the same efficacy and safety review as commercial estradiol tablets [2]. NAMS's 2022 Position Statement states: "There is no evidence that custom-compounded hormones are safer or more effective than well-tested, government-approved hormone therapy products, and they carry their own potential risks." [3] That guidance does not make compounding illegal; it flags the lack of comparative safety data.

Patients choosing compounded oral estradiol should verify that the pharmacy holds an active 503A designation, that the pharmacist can provide a Certificate of Analysis for each batch, and that the prescribing provider is licensed in Wisconsin [8].

Oral Estradiol Insurance Coverage in Wisconsin: What Plans Pay

Most commercial insurance plans sold in Wisconsin, including marketplace plans under the Affordable Care Act, cover oral estradiol as a Tier 1 or Tier 2 generic. The Women's Health Amendment and the ACA's preventive-care provisions do not mandate hormone therapy coverage explicitly, but most formularies include estradiol because it is inexpensive and widely prescribed [11].

Common insurer behavior in Wisconsin for oral estradiol in 2026:

Preferred (Tier 1) placement: Many plans place estradiol 1 mg on Tier 1 with a $0 to $10 copay. Check your plan's Summary of Benefits and Coverage (SBC) or call the member services number on your insurance card before assuming coverage.

Step therapy requirements: Some Wisconsin plans require that patients try a lower dose before approving a higher dose, or that they try one generic manufacturer's product before another. This is more common for doses above 1 mg daily.

Quantity limits: Plans often cap the supply at 30 tablets per 30-day fill. A 90-day supply through a mail-order pharmacy typically lowers the per-tablet cost and reduces the number of trips to the pharmacy.

State employee health plans in Wisconsin, administered through the Group Insurance Board (GIB), cover oral estradiol under their standard formulary with no PA for doses up to 2 mg daily for listed indications. Approximately 260,000 active and retired state employees and dependents in Wisconsin are covered under GIB plans [12].

Under the Inflation Reduction Act provisions now in effect, Medicare Part D enrollees face a $2,000 out-of-pocket cap annually beginning in 2025, which limits total estradiol cost for Medicare-covered seniors even if the plan places it on a mid-tier formulary [13].

The Clinical Evidence Behind Oral Estradiol: Why Dosing Precision Matters

Prescribers in Wisconsin follow the same evidence base as the rest of the country. The Women's Health Initiative (WHI) trial, published in JAMA in 2002 (N=16,608), remains the most cited randomized controlled trial of hormone therapy [14]. The WHI tested conjugated equine estrogen (CEE), not 17-beta-estradiol, and combined it with medroxyprogesterone acetate (MPA) in most arms, a point often missed in patient discussions.

The ELITE trial (Early versus Late Intervention Trial with Estradiol, N=643) published in the New England Journal of Medicine in 2016 showed that oral 17-beta-estradiol 1 mg daily slowed the progression of subclinical atherosclerosis (carotid intima-media thickness) in women who started therapy within 6 years of menopause, but not in those who started more than 10 years after menopause [15]. This finding supports the "timing hypothesis" and guides Wisconsin prescribers toward earlier initiation in appropriate candidates.

A 2017 Cochrane review of short-term use of hormone therapy (HT) for menopausal symptoms (N=22,865 across 46 trials) found that HT reduced the frequency of vasomotor symptoms by approximately 75% compared with placebo [16]. Oral estradiol was among the preparations studied.

The Endocrine Society's 2015 clinical practice guideline on estrogen deficiency in women recommends starting at the lowest effective dose and titrating based on symptom response and serum estradiol levels [7]. For vasomotor symptoms, the typical starting dose is 0.5 mg to 1 mg daily, with titration to 2 mg daily if symptoms persist after 8 to 12 weeks [7]. Starting at 0.5 mg, the least expensive tablet strength available, minimizes both cost and initial estrogenic side effects [2].

A 2022 analysis in Menopause (journal of NAMS) found that oral estradiol achieved therapeutic serum estradiol concentrations (20 to 100 pg/mL) in the majority of postmenopausal women at doses of 1 mg daily, though first-pass hepatic metabolism produces significant inter-individual variability [17]. This variability is one reason some clinicians prefer transdermal routes, though oral tablets remain the most cost-effective option in Wisconsin given their generic availability.

Telehealth Prescribing of Oral Estradiol in Wisconsin

Telehealth prescribing of oral estradiol is fully legal in Wisconsin as of 2026. Wisconsin Statute 448.9875 allows prescribing via synchronous audio-video telehealth after an appropriate clinical evaluation, which for hormone therapy means a symptom history, review of contraindications, and discussion of risks and benefits [18].

A Wisconsin telehealth provider cannot prescribe controlled substances without an in-person visit under current DEA rules, but oral estradiol is not a controlled substance. That distinction means a Wisconsin-licensed clinician can legally write an oral estradiol prescription after a video visit alone, with no prior in-person exam required [18].

Telehealth platforms operating in Wisconsin that prescribe oral estradiol typically charge $0 to $99 for the initial consultation and $0 to $49 per month for follow-up visits, depending on insurance coverage and the platform's business model. Several telehealth platforms accept Wisconsin Medicaid for the consultation, meaning the prescription and the visit may both be covered under ForwardHealth once a PA is obtained [5].

Patients initiating oral estradiol via telehealth in Wisconsin should ask the provider whether they need a progestogen co-prescription. Any patient with an intact uterus requires progestogen to protect the endometrium from estrogen-driven hyperplasia, as demonstrated in multiple RCTs and codified in the NAMS 2022 Position Statement [3, 19].

Wisconsin-Specific Discount Programs and Savings Cards for Oral Estradiol

Several programs can reduce oral estradiol cost in Wisconsin to near zero for cash-pay patients.

GoodRx and RxSaver coupons work at most Wisconsin retail pharmacies, including Walgreens, CVS, Hy-Vee, Pick 'n Save, and Walmart. Presenting a GoodRx code at a Wisconsin Walgreens for estradiol 1 mg (30 tablets) yields prices in the $8 to $12 range as of early 2026. These coupons cannot be combined with insurance.

NeedyMeds Patient Assistance Programs (PAPs): Pfizer, which markets Estrace (brand estradiol), offers a PAP for uninsured or underinsured patients. Income thresholds apply [20].

Wisconsin SeniorCare: The Wisconsin SeniorCare program provides drug coverage for Wisconsin residents aged 65 or older with income below 240% of the federal poverty level. Oral estradiol is a covered drug under SeniorCare's formulary, with a 10% cost-share capped at $29 per prescription [21].

Community Health Centers: Federally Qualified Health Centers (FQHCs) in Wisconsin operate under the 340B Drug Pricing Program, which requires manufacturers to sell outpatient drugs at deeply discounted prices to qualifying entities. Patients receiving care at a Wisconsin FQHC may access oral estradiol at 340B pricing, which can bring the cost to under $5 per month [22].

Manufacturer savings cards: Generic estradiol tablets do not typically carry manufacturer savings cards because they are already inexpensive. Brand-name Estrace cards may reduce the copay for insured patients but are generally less relevant given the price difference between brand and generic.

The HealthRX Wisconsin Oral Estradiol Cost-Minimization Framework ranks access pathways by expected monthly out-of-pocket cost for a typical Wisconsin patient in 2026:

1. Wisconsin Medicaid (ForwardHealth) with approved PA: $1 to $3 per fill
2. Wisconsin SeniorCare (age 65 or older, income-eligible): 10% cost-share, capped at $29 per fill
3. FQHC 340B pricing (care at a qualifying community health center): under $5 per month
4. Commercial insurance, Tier 1 generic: $0 to $10 per month
5. GoodRx or RxSaver coupon, cash pay at discount pharmacy: $8 to $15 per month
6. Standard cash pay, retail pharmacy without coupon: $15 to $40 per month
7. Telehealth platform subscription (consult plus medication bundled): $30 to $99 per month, variable

Any patient who lands in category 6 or 7 should ask their pharmacist or telehealth provider about moving to a lower tier before refilling.

Safety Profile and Contraindications Wisconsin Prescribers Screen For

Oral estradiol is contraindicated in patients with a history of estrogen-dependent breast cancer, undiagnosed abnormal uterine bleeding, active deep vein thrombosis (DVT) or pulmonary embolism (PE), active arterial thromboembolic disease (stroke or MI within the past 12 months), or known protein C, protein S, or antithrombin deficiency [2].

The WHI trial (JAMA 2002, N=16,608) reported an increased risk of stroke (HR 1.41 to 95% CI 1.07 to 1.85) and DVT with combined CEE plus MPA [14]. Subsequent re-analyses and observational studies suggest the thrombotic risk is lower with transdermal estradiol compared with oral estradiol, because transdermal delivery bypasses first-pass hepatic metabolism and produces less hepatic coagulation factor stimulation [23]. Wisconsin prescribers with patients at moderate thrombotic risk sometimes prefer transdermal patches or gels over oral tablets on this basis.

A 2019 BMJ cohort study (N=846,786 women) found that oral estradiol was associated with a higher risk of VTE than transdermal estradiol (incidence rate ratio 1.58 to 95% CI 1.08 to 2.30) [23]. Patients with a personal or family history of VTE should discuss this comparison with their prescriber before committing to an oral formulation.

For patients without contraindications, the benefit-to-risk ratio for oral estradiol in the 50 to 59 age group is favorable for symptom relief, according to the Endocrine Society guideline [7] and the NAMS 2022 Position Statement [3].

How to Start Oral Estradiol in Wisconsin: A Step-by-Step Path

Getting oral estradiol in Wisconsin involves a prescription, a pharmacy visit or mail order, and for most Medicaid patients a PA. Here is the practical sequence:

First, schedule a visit with a Wisconsin-licensed provider, either in-person or via a telehealth platform. Bring a list of current medications, your last menstrual period date or surgical history, and any prior hormone therapy use. The provider will assess your symptoms using the Menopause Rating Scale or a similar tool and rule out contraindications [7].

Second, if you have a uterus, expect the provider to prescribe a progestogen alongside estradiol. Micronized progesterone (Prometrium) 100 mg at bedtime is the most common choice and is also available as a generic at low cost in Wisconsin [3].

Third, ask the provider to send the prescription to the pharmacy with your preferred discount program in mind. If you are on ForwardHealth, ask whether the provider has initiated PA. If they use a telehealth platform, confirm the platform transmits prescriptions to Wisconsin retail pharmacies or that it will work with your local pharmacy.

Fourth, check at least two coupon sites (GoodRx and RxSaver) and compare against your insurance copay before the pharmacist rings you up. The lower price wins.

Starting dose is typically 0.5 mg daily for 8 weeks, with titration to 1 mg daily if vasomotor symptoms persist. Serum estradiol levels drawn 4 to 6 weeks after starting help confirm absorption and guide dose adjustment [7].